Top advances in lung cancer, 2021

• Published in: Cancer Vol. 128; no. 19; pp. 3434 - 3437
• Main Authors: Mohindra, Nisha A., Patel, Jyoti D.
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.10.2022
• Subjects: adjuvant therapy; Cancer screening; Carcinoma, Non-Small-Cell Lung - drug therapy; Carcinoma, Non-Small-Cell Lung - therapy; epidermal growth factor receptor (EGFR) exon 20; ErbB Receptors - genetics; HER2; Humans; Immunotherapy; Kirsten rat sarcoma (KRAS); Lung cancer; Lung Neoplasms - drug therapy; Lung Neoplasms - therapy; Mutation; Oncology; Proto-Oncogene Proteins p21(ras) - genetics; Sarcoma; lung cancer; adjuvant therapy; HER2; epidermal growth factor receptor (EGFR) exon 20; Kirsten rat sarcoma (KRAS)

Despite a global pandemic that continued to inflict chaos and confusion on the world, resulting in fewer cancer screenings and delayed surgeries, remarkable lung cancer treatment advancements were made in 2021. From immunotherapy in the adjuvant setting to the approval of the first‐in‐class, highly...